Pluristem Therapeutics Inc. Forecast, price target & analysts
Pluristem Therapeutics Inc. Target price 2026 - Analyst rating & recommendation
Pluristem Therapeutics Inc. Classifications & Recommendation
Pluristem Therapeutics Inc. Price Target
| Target Price | $12.24 |
| Price | $0.94 |
| Potential | |
| Number of Estimates | 3 |
| 3 Analysts have issued a price target Pluristem Therapeutics Inc. 2027 . The average Pluristem Therapeutics Inc. target price is $12.24. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 7 analysts: 6 Analysts recommend Pluristem Therapeutics Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Pluristem Therapeutics Inc. stock has an average upside potential 2027 of . Most analysts recommend the Pluristem Therapeutics Inc. stock at Purchase. |
Sales and Margin forecast 2027, 2028 & 2029
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Million $ | ??? | ??? |
| ??? | ??? | |
| Net Margin | ??? | ??? |
| ??? | ??? |
3 Analysts have issued a sales forecast Pluristem Therapeutics Inc. 2027 . The average Pluristem Therapeutics Inc. sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
Revenue Estimates
| 2026 | $1.0m | 23.88% |
|---|---|---|
| 2027 | ||
3 Pluristem Therapeutics Inc. Analysts have issued a net profit forecast 2027. The average Pluristem Therapeutics Inc. net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2026 | $-23.8m | 5.49% |
|---|---|---|
| 2027 | ||
Net Margin
| 2026 | -2,335.29% | 38.59% |
|---|---|---|
| 2027 | ||
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029
| Jun '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share $ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
3 Analysts have issued a Pluristem Therapeutics Inc. forecast for earnings per share. The average Pluristem Therapeutics Inc. EPS is
. This is than earnings per share in the financial year 2026. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2026 | $-2.44 | 31.46% |
|---|---|---|
| 2027 | ||
P/E ratio
| Current | -0.42 | 72.42% |
|---|---|---|
| 2027 | ||
Pluristem Therapeutics Inc....
Current Pluristem Therapeutics Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| Analyst Rating | Date |
|---|---|
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
